We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Metabolon Files Patent Infringement Lawsuit against Stemina

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Metabolon Files Patent Infringement Lawsuit against Stemina"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Metabolon, Inc., has filed a patent infringement lawsuit against Stemina Biomarker Discovery, Inc. in the US District Court for the Western District of Wisconsin.

The lawsuit seeks a ruling that Stemina’s services directly infringe on US Patent 7,550,258 and US Patent 7,910,301 which relate to global analysis of complex biological samples for the discovery of biomarkers and pathways associated with drug action, toxicity and disease.